
Xellence Laboratories Private Limited
Pharmaceutical trading company with registered office in Delhi.
Pharmaceutical trading company with registered office in Delhi.
Xellence Laboratories Private Limited (XLPL) is a Private Limited Indian Non-Government Company incorporated in India on 16 January 2006 and has a history of 19 years and one month. Its registered office is in Delhi, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹2.05 M.
Jitender Bansal, Vivek Gambhir, and Divakar Sharma serve as directors at the Company.
Delhi, India
+91-XXXXXXXXXX
-
U24232DL2006PTC144867
144867
Private Limited Indian Non-Government Company
16 Jan 2006
30 Sep 2024
31 Mar 2024
Unlisted
Roc Delhi
Name | Designation | Appointment Date | Status |
---|---|---|---|
Vivek Gambhir ![]() | Director | 16-Jan-2006 | Current |
Jitender Bansal ![]() | Director | 16-Jan-2006 | Current |
Divakar Sharma ![]() | Director | 16-Jan-2006 | Current |
Xellence Laboratories Private Limited, for the financial year ended 2021, experienced significant growth in revenue, with a 163.46% increase. The company also saw a substantial improvement in profitability, with a 516.89% increase in profit. The company's net worth moved up by a moderate rise of 7.43%.
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
In 2021, Xellence Laboratories had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Jitender Bansal is a mutual person
₹2.05 M
₹0
Date | Lender | Amount | Status |
---|---|---|---|
07 Apr 2014 | The Nainital Bank Limited | ₹0.55 M | Open |
14 Dec 2012 | The Nainital Bank Limited | ₹1.50 M | Open |
Unlock and access historical data on people associated with Xellence Laboratories, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Xellence Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Xellence Laboratories's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Xellence Laboratories Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Xellence Laboratories Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi.
A charge with The Nainital Bank Limited amounted to Rs. 0.55 M with Charge ID 10502737 was registered on 07 Apr 2014.
A charge with The Nainital Bank Limited of Rs. 1.50 M registered on 14 Dec 2012 with Charge ID 10396727 was modified on 30 Dec 2013.
A charge with The Nainital Bank Limited amounted to Rs. 1.50 M with Charge ID 10396727 was registered on 14 Dec 2012.
Jitender Bansal was appointed as a Director was appointed as a Director on 16 Jan 2006 & has been associated with this company since 19 years 1 month .
Xellence Laboratories Private Limited was incorporated on 16 Jan 2006.
The authorized share capital of Xellence Laboratories Private Limited is ₹ 0.10 M and paid-up capital is ₹ 0.10 M.
Currently 3 directors are associated with Xellence Laboratories Private Limited.
As per Ministry of Corporate Affairs (Mca), the registered address of Xellence Laboratories Private Limited is Shop 2 6Rashid Market Krishna Nagar India, New Delhi, 110051.
The corporate identification number (CIN) of Xellence Laboratories Private Limited is U24232DL2006PTC144867 and the company number is 144867 as per Ministry of Corporate Affairs (MCA).
According to the financial reports for the fiscal year 2021, the revenue trend for Xellence Laboratories Private Limited has risen by 163.46%.
The financial reports for the fiscal year 2021 indicates that The net worth of Xellence Laboratories Private Limited has experienced an upsurge of 7.43%.
As per the financial statements for fiscal Year 2021, The total open charges for Xellence Laboratories Private Limited amount to ₹ 2.05 M.
The most recent Balance Sheet for Xellence Laboratories Private Limited was filed with the ROC on 31 Mar 2024.
VS